Lithium does not typically lower blood pressure in a clinically meaningful way. Studies comparing people on lithium therapy to those not taking it have found no significant difference in blood pressure readings, whether sitting or standing. However, lithium does interact with the body’s blood pressure regulation systems in complex ways, and it creates important risks when combined with common blood pressure medications.
How Lithium Affects Sodium and Fluid Balance
Lithium influences blood pressure indirectly through its effects on the kidneys. It causes the body to excrete more sodium in urine, a process called natriuresis. Normally, when sodium levels drop, a hormone called aldosterone signals the kidneys to reabsorb sodium and hold onto fluid, which helps maintain blood pressure. But lithium interferes with this system. It reduces the activity of sodium channels in the kidney’s collecting duct, making the kidneys partially resistant to aldosterone’s signal. Even when the body ramps up aldosterone production in response, the kidneys don’t fully respond.
This sets off a chain reaction. The body detects the sodium loss and activates its main blood pressure defense system (the renin-angiotensin system), raising levels of angiotensin II, a potent blood vessel constrictor. This compensatory response is what keeps blood pressure stable in most people taking lithium. Research in lithium-treated patients has confirmed that both renin and aldosterone levels rise significantly, and these levels correlate with how much lithium is in the blood. But because the compensatory system kicks in effectively, blood pressure and electrolyte levels generally stay normal.
Lithium also appears to interfere with angiotensin II signaling itself by inhibiting an enzyme called inositol monophosphatase, which is part of the signaling chain that angiotensin II uses to constrict blood vessels. So lithium simultaneously triggers and partially blunts the body’s blood pressure defense. In most people, these opposing forces balance out, resulting in no net change in blood pressure.
Electrolyte Shifts and Heart Effects
As a charged particle similar in size to sodium and potassium, lithium competes with both of these electrolytes at the cellular level. It can interfere with the sodium-potassium pump that maintains the electrical charge across cell membranes, including heart muscle cells. This competition can decrease potassium inside cells while raising it outside, a combination that affects how electrical signals travel through the heart. These changes show up on an ECG as altered wave patterns rather than as blood pressure changes, but they’re worth understanding because they explain why cardiovascular monitoring is part of standard lithium care.
Why Blood Pressure Monitoring Still Matters
Even though lithium itself doesn’t reliably raise or lower blood pressure, clinicians monitor blood pressure regularly during lithium therapy. An international survey of prescribers found that 88% check blood pressure at least once a year in patients on maintenance lithium, with 44% checking two to three times per year and 21% checking four or more times. This monitoring exists for several reasons.
Long-term lithium use can affect kidney function, and high blood pressure is both a risk factor for and a consequence of kidney disease. Guidelines flag hypertension as a condition that compounds kidney risk in people taking lithium. Monitoring blood pressure helps catch early signs that the kidneys are under strain, especially alongside routine blood tests for kidney function.
Dangerous Interactions With Blood Pressure Drugs
The most practical reason to understand lithium’s relationship with blood pressure is the serious interaction between lithium and several common blood pressure medications. If you take lithium and need treatment for high blood pressure, the choice of medication matters enormously.
Thiazide diuretics (water pills frequently prescribed for hypertension) increase sodium reabsorption in the kidneys, which decreases lithium clearance and can push lithium levels dangerously high. This interaction is significant enough that many prescribers halve the lithium dose when starting a thiazide, then carefully adjust from there. Some avoid thiazides entirely in lithium patients.
ACE inhibitors and angiotensin receptor blockers, two of the most widely prescribed blood pressure drug classes, also reduce lithium clearance. Starting or stopping either type requires closer monitoring of lithium blood levels, and the lithium dose often needs to be reduced. The same applies in reverse: if you stop a blood pressure medication, your lithium levels may drop, potentially reducing its effectiveness.
Even over-the-counter anti-inflammatory drugs like ibuprofen reduce the kidney’s ability to filter lithium, raising blood levels. If you’re on lithium and need pain relief, this interaction is worth discussing with your prescriber.
The Bottom Line on Lithium and Blood Pressure
Lithium creates a tug-of-war in the body’s blood pressure regulation systems, promoting sodium loss on one hand while triggering compensatory hormone responses on the other. For most people, these effects cancel out, and blood pressure stays where it was before starting lithium. The real concern isn’t that lithium will change your blood pressure, but that blood pressure medications can change your lithium levels in ways that lead to toxicity or loss of symptom control. If you’re on lithium and your blood pressure needs treatment, the specific drug chosen and the monitoring that follows are critical decisions that your prescriber will need to make carefully.